Department of Applied Life Sciences, University of Applied Sciences, FH Campus Wien, Helmut-Qualtinger-Gasse 2, 1030, Vienna, Austria.
Mol Biotechnol. 2022 Aug;64(8):873-887. doi: 10.1007/s12033-022-00467-3. Epub 2022 Feb 26.
The heat shock response (HSR) pathway is a highly conserved rescue mechanism, which protects the cells from harmful insults disturbing the cellular protein homeostasis via expression of chaperones. Furthermore, it was demonstrated to play crucial roles in various diseases like neurodegeneration and cancer. For neurodegenerative diseases, an overexpression of chaperones is a potential therapeutic approach to clear the cells from non-functional protein aggregates. Therefore, activators of the HSR pathway and its master regulator HSF1 are under close observation. There are numerous HSR activators published in the literature using different model systems, experimental designs, and readout assays. The aim of this work was to provide a quantitative comparison of a broad range of published activators using a newly developed HSF responsive dual-luciferase cell line. Contrary to natural target genes, which are regulated by multiple input pathways, the artificial reporter exclusively reacts to HSF activity. In addition, the results were compared to endogenous heat shock protein expression. As a result, great differences in the intensity of pathway activation were observed. In addition, a parallel viability assessment revealed high variability in the specificity of the drugs. Furthermore, the differences seen compared to published data indicate that some activators exhibit tissue-specific differences leading to interesting assumptions about the regulation of HSF1.
热休克反应 (HSR) 途径是一种高度保守的保护机制,通过表达伴侣蛋白来保护细胞免受破坏细胞蛋白平衡的有害刺激。此外,它在神经退行性疾病和癌症等各种疾病中发挥着关键作用。对于神经退行性疾病,伴侣蛋白的过表达是清除细胞中非功能性蛋白聚集体的一种潜在治疗方法。因此,HSR 途径及其主调控因子 HSF1 的激活剂受到密切关注。文献中已经发表了许多 HSR 激活剂,它们使用不同的模型系统、实验设计和读数测定方法。这项工作的目的是使用新开发的 HSF 反应性双荧光素酶细胞系对广泛的已发表激活剂进行定量比较。与受多种输入途径调节的天然靶基因不同,人工报告基因仅对 HSF 活性作出反应。此外,将结果与内源性热休克蛋白表达进行了比较。结果观察到途径激活的强度存在很大差异。此外,平行的生存能力评估显示药物的特异性存在很大差异。此外,与已发表数据相比存在的差异表明,一些激活剂表现出组织特异性差异,这使得人们对 HSF1 的调控产生了有趣的假设。